A Phase II trial of AstroStem for treatment of Alzheimer's disease.
Phase of Trial: Phase II
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 10 Mar 2017 Status changed from not yet recruiting to recruiting, as reported in a Nature Cell media release.
- 08 Mar 2017 According to a Nature Cell media release, IRB final approval was obtained for the two hospitals in the U.S.:Syrentis Clinical Research and ATP Clinical
- 28 Feb 2017 IRB approval was obtained regarding the clinical trial protocol, as reported in a Nature Cell media release.